Indikationen for Keppra er monoterapibehandling af patienter over 16 år, som for nyligt har fået stillet diagnosen partiel epilepsi med eller uden sekundær generalisering.
Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.